The ASIST study will assess the safety and efficacy of BXQ-350 plus SOC, modified FOLFOX7 (mFOLFOX7) and bevacizumab, in patients with newly diagnosed mCRC. The study is also evaluating whether the ...

JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on November 13. Debanjana ...

Leading the Way in Specialized Diabetic Foot Care in Delhi NCRDelhi, India - November 17, 2024 — Diabetes, often called the ...

Higher Dimensions of Healing is excited to announce the opening of its Psychedelic Wellness Center, located at 1950 E College ...

An expert has flagged the common signs of diabetes, including a common nighttime habit. As World Diabetes Day was marked on ...

And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

Here's how diabetic foot diseases and foot ulcers are caused, who is at risk, signs to watch and expert tips to prevent or ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...